Wild-type Ras proteins may even promote more malignant stages of tumorigenesis, as shRNA-mediated knock down of wild-type Ras proteins has been shown to inhibit the tumor growth of KRAS mutation-positive cancer cell lines isolated from late stage disease [8–10, 19]. Here, KRAS is linked to neoplasm.